AGENT FOR ALLEVIATION OF FUNCTIONAL DISORDER AFTER CARDIOPULMONARY RESUSCITATION

Details for Australian Patent Application No. 2003275707 (hide)

Owner MITSUBISHI PHARMA CORPORATION

Inventors AKIYAMA, Katsunori

Pub. Number AU-A-2003275707

PCT Number PCT/JP03/13769

PCT Pub. Number WO2004/037249

Priority 60/421,619 28.10.02 US

Filing date 28 October 2003

Wipo publication date 13 May 2004

International Classifications

A61K 031/4152 - having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone

A61P 011/00 Drugs for disorders of the respiratory system

A61P 043/00 Drugs for specific purposes, not provided for in groups

C07D 231/26 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

Event Publications

12 February 2004 Complete Application Filed

  Priority application(s): 60/421,619 28.10.02 US

17 June 2004 Application Open to Public Inspection

  Published as AU-A-2003275707

14 July 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003275708-CHEMICALLY STRENGTHENED GLASS, SUBSTRATE FOR INFORMATION RECORDING MEDIUM AND INFORMATION RECORDING MEDIUM

2003275706-METHOD OF CONTROLLING MIGRATION OF SUBSTANCE